Aspartate β-hydroxylase as a target for cancer therapy | Journal of Experimental & Clinical Cancer Research | Full Text

Aspartate β-hydroxylase as a target for cancer therapy | Journal of Experimental & Clinical Cancer Research | Full Text

Aspartate β-hydroxylase as a target for cancer therapy

As metastasis is a major cause of death in cancer patients, new anti-metastatic strategies are needed to improve cancer therapy outcomes. Numerous pathways have been shown to contribute to migration and invasi...

Authors:Madiha Kanwal, Michal Smahel, Mark Olsen, Jana Smahelova and Ruth Tachezy

Citation:Journal of Experimental & Clinical Cancer Research 2020 39:163

Content type:Review

 

Published on: 18 August 2020

• ViewFull Text
 
• ViewPDF